Carcinoma, Squamous Cell of the Head and Neck
3 clinical trials · Condition
◉ Watch Carcinoma, Squamous Cell of the Head and Neck
| Record | Firm | Date |
|---|---|---|
| Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC) (NCT02573493) | Washington University School of Medicine | 2016-04-13 |
| Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers (NCT01166542) | Oncolytics Biotech | 2010-06-01 |
| Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carcinoma (NCT00753038) | Oncolytics Biotech | 2008-08-01 |
Track Carcinoma, Squamous Cell of the Head and Neck automatically
Every clearance here is in the API, with alerts when new ones post.